Quarterly Result11 Feb 2026, 07:13 pm
Bal Pharma Reports Q3 FY2025 Unaudited Standalone Financial Results with a Net Profit of ₹ 194.62 Lakhs
AI Summary
Bal Pharma Ltd. has announced its unaudited standalone financial results for the quarter and nine months ended 31.12.2025. The company's revenue from operations stands at ₹ 8,749.48 Lakhs, with a net profit of ₹ 194.62 Lakhs. The results have been reviewed by the Audit Committee and approved by the Board of Directors. The standalone financial results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015.
Key Highlights
- Revenue from operations for Q3 FY2025 is ₹ 8,749.48 Lakhs.
- Net profit for Q3 FY2025 is ₹ 194.62 Lakhs.
- The standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors.
- The results have been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015.
Price Impact
More from BALPHARMA